University of Glasgow | December 2018 | £1000: The cost of delivering a type 2 diabetes remission programme in the NHS
A new study that involved researchers from the universities of Glasgow and Newcastle suggests rolling out a Type 2 diabetes remission programme in the NHS could cost around £1,067 per participant in its first year – or, factoring in the likelihood of success, £2,564 for each case of remission. Researchers say findings ‘make the case for shifting resources to offer remission’ in the future.
Calculating the cost of the the 12-month programme, accounting for savings for reduced drug and medical needs, was £1,067. The researchers compared the treatment costs of the two groups in DiRECT: those on the weight loss programme (the intervention group), and those receiving current standard NHS care (the control group).
Mike Lean, Professor of Human Nutrition at the University of Glasgow and consultant physician at Glasgow Royal Infirmary, said: “The cost of a year’s programme to achieve remission of Type 2 diabetes is less than the annual cost of continuing to treat this progressive and often debilitating condition – particularly at its later stages. It is becoming hard to see why, ethically, people with Type 2 diabetes should not be offered the chance, and supported, to achieve remission if they can. This is no quick fix, but instead a promising medical treatment with potentially huge benefits.”
DiRECT is testing a low-calorie weight management programme in over 300 people across Glasgow and Tyneside. The programme, which involves an 800 calorie liquid diet and structured, long-term support from a healthcare professional to reintroduce healthy food and maintain the weight loss, is aiming to establish if the approach could put people with Type 2 diabetes into remission and keep them there in the longer term.
The programme is delivered within NHS primary care, it is relatively inexpensive compared to serious and expensive complications of Type 2 diabetes
A new study suggests rolling out a Type 2 diabetes remission programme in the NHS could cost around £1,067 per participant in its first year – or, factoring in the likelihood of success, £2,564 for each case of remission. Researchers say findings ‘make the case for shifting resources to offer remission’ in the future (Source: University of Glasgow).
Read more about the research in this press release University of Glasgow
The article is available to read from the Lancet Diabetes & Endocrinology